Michael Carey Selected Research

tumor-associated transplantation antigen (TSTA)

1/2006	Noninvasive indirect imaging of vascular endothelial growth factor gene expression using bioluminescence imaging in living transgenic mice.
1/2006	Bioluminescence imaging of systemic tumor targeting using a prostate-specific lentiviral vector.
5/2005	Functionality of androgen receptor-based gene expression imaging in hormone refractory prostate cancer.
9/2004	Noninvasive imaging of enhanced prostate-specific gene expression using a two-step transcriptional amplification-based lentivirus vector.
11/2003	Optimization of adenoviral vectors to direct highly amplified prostate-specific expression for imaging and gene therapy.
3/2002	Molecular engineering of a two-step transcription amplification (TSTA) system for transgene delivery in prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Carey Research Topics

Disease

11	Neoplasms (Cancer) 05/2009 - 08/2002
7	Prostatic Neoplasms (Prostate Cancer) 11/2006 - 03/2002
2	Pain (Aches) 01/2015 - 07/2010
2	Wounds and Injuries (Trauma) 05/2008 - 01/2006
1	Hypersensitivity (Allergy) 01/2022
1	Anaphylaxis (Anaphylactic Shock) 01/2022
1	Drug Hypersensitivity (Drug Allergy) 01/2022
1	Leiomyoma (Uterine Fibroids) 08/2011
1	Placenta Previa 08/2011
1	Thrombocytopenia (Thrombopenia) 08/2011
1	Postoperative Pain 07/2010
1	Maternal Death 08/2009
1	Neoplasm Metastasis (Metastasis) 05/2009
1	Breast Neoplasms (Breast Cancer) 05/2009
1	Sepsis (Septicemia) 09/2006
1	Esophageal Neoplasms (Esophageal Cancer) 09/2006
1	Disease Progression 11/2005
1	Herpes Simplex 10/2005
1	Acidosis 09/2005
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 08/2003

Drug/Important Bio-Agent (IBA)

6	tumor-associated transplantation antigen (TSTA)IBA 01/2006 - 03/2002
5	Prostate-Specific Antigen (Semenogelase)IBA 11/2005 - 08/2002
5	AndrogensIBA 11/2005 - 03/2002
3	Androgen Receptors (Androgen Receptor)IBA 11/2005 - 08/2003
3	Firefly LuciferasesIBA 08/2003 - 03/2002
2	LuciferasesIBA 05/2009 - 10/2005
2	Hormones (Hormone)IBA 11/2005 - 05/2005
2	Thymidine KinaseIBA 10/2005 - 05/2005
1	COVID-19 VaccinesIBA 01/2022
1	Excipients (Suspending Agents)IBA 01/2022
1	Tromethamine (Trometamol)FDA Link 01/2022
1	Polysorbates (PSML)FDA Link 01/2022
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2022
1	VaccinesIBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2015
1	AnticoagulantsIBA 08/2011
1	Anesthetics (Anesthetic Agents)IBA 07/2010
1	Sevoflurane (Ultane)FDA LinkGeneric 07/2010
1	Propofol (Diprivan)FDA LinkGeneric 07/2010
1	Mucin-1 (CA 15-3 Antigen)IBA 05/2009
1	SurvivinIBA 11/2008
1	Epidermal Growth Factor (EGF)IBA 11/2006
1	Mitogen-Activated Protein KinasesIBA 11/2006
1	Phosphotransferases (Kinase)IBA 11/2006
1	Mitogen-Activated Protein Kinase 3IBA 11/2006
1	Proteins (Proteins, Gene)FDA Link 01/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2006
1	Androgen Antagonists (Antiandrogens)IBA 11/2005
1	Flutamide (Eulexin)FDA LinkGeneric 11/2005
1	HLA Antigens (Human Leukocyte Antigens)IBA 09/2005
1	L-SelectinIBA 09/2005
1	C-Reactive ProteinIBA 09/2005
1	LigandsIBA 08/2003
1	ChromatinIBA 08/2003
1	D-luciferinIBA 08/2003

Therapy/Procedure

2	Therapeutics 11/2008 - 09/2004
1	Ambulatory Surgical Procedures (Outpatient Surgery) 07/2010
1	Blood Transfusion (Blood Transfusions) 08/2009
1	Conduction Anesthesia (Regional Anesthesia) 05/2008
1	Radiotherapy 09/2006
1	Neoadjuvant Therapy 09/2006
1	Esophagectomy 09/2006
1	Intravenous Administration 01/2006
1	Castration 08/2003
1	Optical Devices 08/2003